Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CTSA | P10619 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16866792 | 0.79 | ALDH1A1 (0.45) | ALDH1A1KDM4EPOLBCTSAACHE | |
| SCHEMBL13675404 | 0.69 | — | — | |
| SCHEMBL13656402 | 0.68 | ABCB11 (0.36) | ALDH1A1KDM4EPOLBCTSAACHE | |
| SCHEMBL10308497 | 0.67 | — | — | |
| Methane SCHEMBL11428409 | 0.65 | — | — | |
| SCHEMBL7537376 | 0.65 | CTSA (0.67) | ALDH1A1KDM4EPOLBCTSAACHE | |
| SCHEMBL80155 | 0.64 | CTSA (0.56) | ALDH1A1KDM4EPOLBCTSAACHE | |
| SCHEMBL12207861 | 0.63 | — | — | |
| SCHEMBL21906271 | 0.63 | TSHR (0.46) | — | |
| SCHEMBL25174107 | 0.61 | CTSA (0.53) | ALDH1A1KDM4EPOLBCTSAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3821884-A1 | USE OF COMPOUND IN DRUG FOR PREVENTING, TREATING, OR ALLEVIATING PAIN | Ascentawits Pharmaceuticals, Ltd. (CN) | 2021-05-19 | — | — | EP | disclosed |
| US-7605144-B2 | Enzyme catalyzed therapeutic compounds | CELMED ONCOLOGY (USA), INC. (CA) | 2009-10-20 | — | — | US | disclosed |
| US-7605144-B2 | Enzyme catalyzed therapeutic compounds | CELMED ONCOLOGY (USA), INC. (CA) | 2009-10-20 | — | — | US | disclosed |
| US-7601703-B2 | Enzyme catalyzed therapeutic agents | CELMED ONCOLOGY (USA), INC. (CA) | 2009-10-13 | — | — | US | disclosed |